Screening Unit Cost Methodology
How We Define and Price "One Screening"
When Breast Cancer Charity states that “£25 funds one complete breast cancer screening”, we are describing a fully calculated programme unit cost in partner health settings in low- and middle-income countries.
This £25 unit cost is not an invoice for a UK private clinic mammogram (which typically costs £150–£350 privately in the UK), nor is it an NHS service charge (which is 100% free at point of care for eligible UK residents).
Instead, £25 covers the composite cost of delivering an end-to-end community screening intervention overseas:
- Clinical Breast Examination (CBE): Screening conducted by trained local female healthcare workers or nurses.
- Targeted Ultrasound Scan: Diagnostic imaging for women with suspicious lumps or dense tissue.
- Patient Health Education & TLC Guides: Vernacular educational pamphlets and self-examination materials.
- Mobile Outreach Unit Logistics: Vehicle fuel, transport, and equipment maintenance for remote rural screening camps.
Detailed Unit Cost Breakdown Table
| Impact Tier | Cost | Intervention Details Included |
|---|---|---|
| Single Screening | £25 | CBE exam + ultrasound triage + health awareness kit in outreach camps. |
| Diagnostic Biopsy Support | £75 | Core needle biopsy + pathology lab analysis + histology reporting for suspicious lesions. |
| Hormone Therapy Support | £150 | One month of hormone therapy support: the medicine (such as tamoxifen), a clinic consultation and lab monitoring. |
| Surgical Access Support | £500 | Hospital co-payment, transport, accommodation and surgical follow-up for one patient. |
These are illustrative programme costs. Actual costs and services vary by partner and place, and donations are pooled according to need.
All unit cost data is published in machine-readable Open Knowledge Format (OKF) at /data/screening-unit-cost-economics.csv.
Data Sources & Global Survival Gap Verification
Our educational guides frequently highlight the stark global survival gap in breast cancer:
- High-income countries: five-year net survival was 87.3% in 2017–2021 (WHO Global Breast Cancer Initiative). In the UK it is almost 90% (Cancer Research UK, England and Wales, women).
- Low-income countries: five-year net survival was 41.9% over the same period (WHO Global Breast Cancer Initiative). WHO’s goal is for more than 60% of invasive breast cancers to be diagnosed at stage I or II (WHO: the three pillars).
Anti-Fabrication & Zero-Counter Rules
We adhere to strict zero-fabrication standards. We do not publish automated "lives saved" counter widgets or ticker animations that estimate impact without verified hospital receipts. Impact dashboards remain at exact audited figures until independent partner reports are verified.
Medical & Service Disclaimers
This methodology page explains donor unit cost calculations for overseas health programmes. It is not for UK readers seeking NHS mammograms or GP appointments.